P309-2791 Screening compound: N-{3-[4-(2-methoxyphenyl)piperazine-1-carbonyl]pyrazin-2-yl}benzamide

P309-2791 Screening compound: N-{3-[4-(2-methoxyphenyl)piperazine-1-carbonyl]pyrazin-2-yl}benzamide
P309-2791 Screening compound: N-{3-[4-(2-methoxyphenyl)piperazine-1-carbonyl]pyrazin-2-yl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P309-2791
N-{3-[4-(2-methoxyphenyl)piperazine-1-carbonyl]pyrazin-2-yl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P309-2791

Molecular Formula

C23H23N5O3 (C23 H23 N5 O3)

Compound Name

N-{3-[4-(2-methoxyphenyl)piperazine-1-carbonyl]pyrazin-2-yl}benzamide

IUPAC name

N-{3-[4-(2-methoxyphenyl)piperazine-1-carbonyl]pyrazin-2-yl}benzamide

SMILES

COc(cccc1)c1N(CC1)CCN1C(c1nccnc1NC(c1ccccc1)=O)=O

InChI

InChI=1S/C23H23N5O3/c1-31-19-10-6-5-9-18(19)27-13-15-28(16-14-27)23(30)20-21(25-12-11-24-20)26-22(29)17-7-3-2-4-8-17/h2-12H,13-16H2,1H3,(H,25,26,29)

InChI Key

WPJSPXMKAHOGMX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27571526

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

417.47

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.331

Distribution Coefficient, logD

0.893

Water Solubility, LogSw

-2.83

Polar Surface Area

70.074

Acid Dissociation Constant (pKa)

5.98

Base Dissociation Constant (pKb)

5.56

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.70

P309-2791 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Proteases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P309-2791 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P309-2791?
Check Price and Availability of P309-2791, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P309-2791 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P309-2791
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P309-2791
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P309-2791 available by request